Schedule Your Free Consultation

Bayer Settles Yasmin and Yaz Lawsuits, No Word on Beyaz

Although Beyaz side effects are similar to those of Yasmin and Yaz, and even though some lawsuits name all three birth control pills, Bayer's Annual Report 2013 does not mention Beyaz in its Legal Risks Section. The Annual Report discusses other Beyaz lawsuit risks, but not those alleging side effects from Beyaz birth control.

Beyaz, like Yasmin and Yaz, is oral birth control that contains drospirenone. Drospirenone has been linked to an increased risk of blood clots in women that use birth control. All three drugs have been named in lawsuits alleging Bayer, maker of Yasmin, Yaz, and Beyaz failed to adequately warn patients and medical professionals about the risk of blood clots linked to birth control. Beyaz is slightly different from Yasmin and Yaz in that it also contains folate.

Bayer's Annual Report 2013 (found online at refers to Yasmin and Yaz litigation in its Legal Risks section. The Annual Report notes that as of February 10, 2014, the number of claimants in pending lawsuits concerning Yasmin and Yaz was around 4,600. The report also mentions Ocella and Gianvi, generic versions of Yasmin and Yaz. Claimants in those lawsuits allege they suffered serious personal injuries from use of the birth control pills. To read the entire article click here.


Why Choose Our Firm?

  • Over 50 Years of Experience
  • Honest and Personalized Communication
  • Dedicated to Helping You Get Your Life Back
  • Committed to Our Community
  • Compassionate in Our Approach

An Experienced Team
You Can Trust


More Than A Case

Our Clients Are Our Priority
  • “Dedicated and Professional”

  • “Attorney Kristin Merrick”

    - Chengyuan He

Contact Us

Schedule Your Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please make a selection.
  • Please enter a message.